Navigation Links
BioLife Solutions Expands Presence in Cell Therapy and Cord Blood Banking Market Segments
Date:3/27/2008

merous new customers in the cellular therapy market as a result of repeatedly demonstrated improvements in yield, quality, and costs related to biopreservation of biologic source material and manufactured cell therapy products. Over one hundred cell therapy companies have evaluated or adopted HypoThermosol(R) and/or CryoStor for use in the production of novel cellular therapy products targeting a multitude of diseases and disorders such as cancer, heart failure, vision loss, neurologic disorders, and many others. Our products also extend the shelf life and transport time of both very precious blood and tissue based source material as well as for final cell-based clinical products. Several customers have commented that use of our products is critical to enabling eventual commercialization of their cell-based therapies."

About Oncolix

Oncolix is a drug development company focused on treatments for cancer. The company is currently evaluating Melaxin(R), a cellular therapy, for the treatment of metastatic melanoma in a Phase IIa clinical trial. In addition, the Company has a prolactin receptor antagonist (Prolanta(R)) for the treatment of breast cancer, which is expected to be evaluated in a Phase I trial in early 2009.

About BioLife Solutions

BioLife Solutions develops and markets patented hypothermic storage/transport and cryopreservation media products for cells, tissues, and organs. The Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of preservation media products are marketed to academic research institutions, clinical care provider organizations, and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced, delayed-onset cell damage and death. BioLife's enabling technology provides research and clinical organizations significant improve
'/>"/>

SOURCE BioLife Solutions Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
2. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
3. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
4. SXC Health Solutions to present at the 2007 UBS Global Life Sciences Conference
5. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
6. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
7. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
8. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
9. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
10. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
11. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center fo...ornia to provide protection for cash paying patien...panic community is benefiting. , ... Dr. Milton Owens and the Coastal Center for Obesi...o provide protection for cash paying patients in t...
(Date:8/28/2008)...th person with dementia led to daytime tiredness, .... 28 (HealthDay News) -- Older adults who live wit...eone with dementia have significantly worse sleep ..., The study compared 31 caregivers and 102 noncar...minutes less per night than non-caregivers and too...
(Date:8/28/2008)...lead clinical efforts of the Maryland Medicaid con...ePRO, a national medical,management firm, appointe...ical Director. Dr. Lawyer will oversee all clinica...n KePRO,s Hunt Valley, Maryland Harrisburg,office....reer in Maryland," said,Alice Stollenwerk Petrulis...
(Date:8/28/2008)... stroke risk by 67%, but patients and doctors say .... 28 (HealthDay News) -- Only 40 percent of patien...or stroke, who did suffer a stroke were taking the..., Among those taking warfarin, 75 percent weren,... an additional 25 percent were taking medications ...
Breaking Medicine News(10 mins):Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3
... University, has developed a three-dimensional ima...on its surface, which aids in fusing// with human ... year when it was diagnosed. Findings from this ...t of vaccines that will thwart infection by target...
...arch has found that daily intake of alcohol may re...drinks occasionally//. But the research has conclu...re deprived of it. This study raises important que...rt health among men and women, but an editorial wa...
...h toll rising to over 3500 and an incalculable num...asured 6.2 on scale, Indonesia struggles// to cope...densely populated area in the south of the city of... coast of Java at 10.53PM late on the Friday night...
...regnancy Advisory Service (BPAS) has announced tha...en in the first nine weeks of pregnancy had involv...dical abortion. The latest figures reveal that th...ain has reached an all time high with 10,000 pregn...
Other Medicine News:Health News:Three-Dimensional Image Of AIDS Virus – BY FSU Researcher 2Health News:Three-Dimensional Image Of AIDS Virus – BY FSU Researcher 3Health News:Daily Intake Of Alcohol Reduces Heart Disease In Men Than Women 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2Health News:Record Number Of Women Use Abortion Pills 2
(Date:8/26/2008)...APOLIS, Aug. 26 /- Semafore Pharmaceu...h International Congress on Targeted,Therapies in ...iangiogenic,activity of vascular-targeted PI3 kina...and Bv8 signaling., PI3K is part of a very powerf...n shown to play a major role in cancer. Studies ha...
(Date:8/26/2008)...PARK, Calif., Aug. 26 /- XT...e positive one-year follow-up data,from the CUSTOM...f the,peer-reviewed journal, EuroIntervention. The...la, M.D., of University Medical Center Utrecht, Ut...Investigators from 13 clinical,sites across Europe...
(Date:8/25/2008)...LEY HILLS, Mass., Aug. 25 /- Joseph F...ts of Spherics, Inc. ("Spherics") for,the benefit ...cal,intellectual property will be sold at a sealed...extended release formulation of Levodopa-Carbidopa...arkinson,s disease, with global,sales estimated at...
(Date:8/22/2008)...G, Germany, August 22 /-, - Dangerou...very Year, Sometimes something well-tried can als... was considered to be very antimicrobial. This,abi...gle against dangerous,hospital germs. In a worldwi...Asklepios Clinic in Wandsbek in Hamburg, Germany, ...
Breaking Medicine Technology:SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3New Report Tackles the Changing Landscape for Alzheimers Diagnostics and Treatments 2784 1New Report Tackles the Changing Landscape for Alzheimers Diagnostics and Treatments 2784 2Cell Therapeutics Inc 28CTI 29 Shareholders Authorize Share Increase at Special Meeting of Shareholders 2781 1Cell Therapeutics Inc 28CTI 29 Shareholders Authorize Share Increase at Special Meeting of Shareholders 2781 2Pancreatic cancer 3A The smaller the tumor the better your chances study shows 10274 1Pancreatic cancer 3A The smaller the tumor the better your chances study shows 10274 2Pancreatic cancer 3A The smaller the tumor the better your chances study shows 10274 3VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 10271 1VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 10271 2VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 10271 3VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 10271 4
...S WIRE)--May 24, 2007 - ImmunoGen, Inc.,(Nasdaq: I...rgeted,anticancer therapeutics using its Tumor-Act...hat clinical findings for three,different TAP comp...reported at the 43rd American Society of Clinical ...1-5, 2007 in Chicago, IL., Trastuzumab-DM1 (abstra...
...S WIRE)--May 25, 2007 - ARIAD,Pharmaceuticals, Inc...estigators from leading cancer centers will presen... of the Company,s novel mTOR,inhibitor, AP23573, a...inical Oncology (ASCO) in Chicago, Illinois, on Su... 2 trial of single-agent,AP23573 in patients with ...
Other Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4
... 96 and E-Gel® 48 gels run in the specially de...combine the base and power supply in one device. T...other E-Base™ and to other daughter E-Base&t...is of two or more E-Gel® 96 or E-Gel® 48 g...
...™ 96 High-throughput protein electrophoresis...ning of proteins via western blotting or in gel st...cast gels that include a buffered gel matrix and e...ent cassette; Mother E-Base power device; Daughter...
The Classic Series gel tanks come with turn and cast gel trays or gasketed gel trays, making gel pouring as simple as possible. , Designed to give you total felxibility in your application. Avaialbl
...orizontal Gel System provides a compact format to ...s, PCR products and synthetic oligonucleotides, wh...., The Mini Horizontal Unit has gel bed dimension...nt. Adjustable height Combs are offered in several...
Medicine Products: